CSIMarket Company Name, Ticker, Suppliers, else..
 


Biotechnology & Drugs Industry Profitability

Profitability Information & Trends 
  
Category:   Period:  

Biotechnology & Drugs Industry Profitability Ratios 4 Q 2019 3 Q 2019 2 Q 2019 1 Q 2019 4 Q 2018
  2019 2019 2019 2019 2018
Gross Margin 77.91 % 80.82 % 80.99 % 80.5 % 76.05 %
Gross Margin Annual (TTM) 79.02 % 79.28 % 79.2 % 78.97 % 79.39 %
Gross Margin Ranking # 20 # 8 # 10 # 5 # 8
EBITDA Margin 47.91 % 10.96 % 17.85 % 23.8 % -
EBITDA Margin Annual (TTM) 21.39 % 8.42 % 13.88 % 17.28 % 22.73 %
EBITDA Margin Ranking # 8 # 67 # 41 # 25 # 103
Operating Margin 15.82 % 4.22 % 21.83 % 14.55 % -
Operating Margin Annual (TTM) 9.15 % 3.27 % 8.84 % 9.43 % 17.9 %
Operating Margin Ranking # 34 # 85 # 21 # 40 # 99
Pre-Tax Margin 14.71 % 1.01 % 9.45 % 14.32 % -
Pre-Tax Margin Annual (TTM) 5.52 % - 4.52 % 7.91 % 15.44 %
Pre-Tax Margin Ranking # 24 # 92 # 46 # 27 # 104
Net Margin 15.54 % 0.66 % 4.41 % 10.5 % -
Net Margin Annual (TTM) 4.24 % - 1.86 % 5.68 % 13.27 %
Net Margin Ranking # 24 # 90 # 70 # 36 # 104

New: More Biotechnology & Drugs Industry historic profitability ratios >>

Comment on the 4 Q 2019 Gross Margin within the Biotechnology & Drugs Industry

Biotechnology & Drugs Industry's Revenue increased sequentially by 4.91 % faster than Gross Profit increase of 1.89 %, this led to contraction in Gross Margin to 77.91 %, higher than Industry average.

On the trailing twelve months basis gross margin in 4 Q 2019 fell to 79.02 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved the highest gross margin. Gross margin total ranking has deteriorated compare to previous quarter from 8 to 20.

Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.

Gross Margin Statistics
High Average Low
102.36 % 77.16 % 61.7 %
4. quarter 2013   4. quarter 2021

Gross Margin Industry Ranking
Within: No.
Healthcare Sector # 1
Overall # 20


Other Gross Margins
Compare Industry's gross margin to Powl's or S&P Gross profits within Biotechnology & Drugs Industry
Highest Ranking Gross Margins Lowest Ranking Gross Margins
Profitability for Powl's Suppliers Definiton of Gross Margin

Biotechnology & Drugs Industry EBITDA Margin Statistics
 
EBITDA Margin Statistics
High Average Low
47.91 % 26.83 % -16.18 %
4. quarter 2019   4. quarter 2021

EBITDA Margin Industry Ranking
Within: No.
Healthcare Sector # 1
Overall # 8

EBITDA Margin Comment on the 4 Q 2019 within the Biotechnology & Drugs Industry

Biotechnology & Drugs Industry Ebitda grew by 340.78 % in 4 Q 2019 sequentially, while Revenue increased by 4.91 %, this led to improvement in Biotechnology & Drugs Industry's Ebitda Margin to 47.91 % a new Industry high.

On the trailing twelve months basis Ebitda Margin in 4 Q 2019 grew to 21.39 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest ebitda margin. Ebitda margin total ranking has impoved so far to 8, from total ranking in previous quarter at 67.

Other EBITDA Margins
Compare Industry's EBITDA margin to Powl's or S&P Gross profits within Biotechnology & Drugs Industry
Highest Ranking EBITDA Margins Lowest Ranking EBITDA Margins
Profitability for Industry's Suppliers Industry Net Cash Flow Margin


Biotechnology & Drugs Industry Operating Margin Statistics
 

Operating Margin Comment on the 4 Q 2019 within the Biotechnology & Drugs Industry

Biotechnology & Drugs Industry Operating Profit grew by 313.6 % in 4 Q 2019 sequentially, while Revenue increased by 4.91 %, this led to improvement in Biotechnology & Drugs Industry's Operating Margin to 15.82 %, Operating Margin remained below Biotechnology & Drugs Industry average.

On the trailing twelve months basis operating margin in 4 Q 2019 grew to 9.15 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest operating margin. Operating margin total ranking has impoved so far to 34, from total ranking in previous quarter at 85.



Operating Margin Statistics
High Average Low
41.3 % 21.93 % -10.83 %
4. quarter 2015   4. quarter 2018

Operating Margin Industry Ranking
Within: No.
Healthcare Sector # 1
Overall # 34

Biotechnology & Drugs Industry Pre-Tax Margin Statistics
 


Pre-Tax Margin Statistics
High Average Low
38.85 % 18.19 % -12.75 %
4. quarter 2015   4. quarter 2018

Comment on the 4 Q 2019 Pre-Tax Margin in the Biotechnology & Drugs Industry

Biotechnology & Drugs Industry Pre-Tax Income grew by 1139.25 % in 4 Q 2019 sequentially, while Revenue increased by 4.91 %, this led to improvement in Biotechnology & Drugs Industry's Pre-Tax Margin to 14.71 %, Pre-Tax Margin remained below Biotechnology & Drugs Industry average.

On the trailing twelve months basis Pre-Tax Margin in 4 Q 2019 grew to 5.52 %.

Within Healthcare sector only one Industry has achieved higher Pre-Tax Margin. Pre-Tax Margin total ranking has impoved so far to 24, from total ranking in previous quarter at 92.
Pre-Tax Margin Industry Ranking
Within: No.
Healthcare Sector # 2
Overall # 24

Pre-Tax Margins
Compare Industry's pre-tax margin to Powl's or S&P Net profits within Biotechnology & Drugs Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Powl's Competitors Industry Tax Rate


Biotechnology & Drugs Industry Net Margin Statistics
 





Net Margin Comment on the 4 Q 2019 in the Biotechnology & Drugs Industry

Biotechnology & Drugs Industry Net Profit grew by 1658.63 % in 4 Q 2019 sequentially, while Revenue increased by 4.91 %, this led to improvement in Biotechnology & Drugs Industry's Net Margin to 15.54 %, above Biotechnology & Drugs Industry average Net Margin.

On the trailing twelve months basis Net margin in 4 Q 2019 grew to 4.24 %.

Within Healthcare sector 2 other industries have achieved higher Net margin. Net margin total ranking has impoved so far to 24, from total ranking in previous quarter at 90.

Net Margin Statistics
High Average Low
32.97 % 13.47 % -18.25 %
4. quarter 2015   4. quarter 2017
Net Margin Industry Ranking
Within: No.
Healthcare Sector # 3
Overall # 24

Other Net Margins
Compare Industry's net margin to Powl's or S&P Net profits within Biotechnology & Drugs Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Powl's Suppliers Definiton of Net Margin





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com